II

Ishara Investments Portfolio holdings

AUM $85.9M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$85.9M
AUM Growth
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
38
New
Increased
Reduced
Closed

Top Buys

1 +$7.45M
2 +$6.3M
3 +$5.44M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$3.82M
5
FOLD icon
Amicus Therapeutics
FOLD
+$3.54M

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 97.8%
2 Industrials 2.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRAX icon
1
Praxis Precision Medicines
PRAX
$9.64B
$11.8M 13.72%
+40,000
XERS icon
2
Xeris Biopharma Holdings
XERS
$1.11B
$6.28M 7.31%
+800,000
BMRN icon
3
BioMarin Pharmaceuticals
BMRN
$11.8B
$5.94M 6.92%
+100,000
FOLD icon
4
Amicus Therapeutics
FOLD
$4.5B
$5.13M 5.97%
+360,000
ACAD icon
5
Acadia Pharmaceuticals
ACAD
$4.22B
$4.27M 4.97%
+160,000
ANNX icon
6
Annexon
ANNX
$759M
$3.77M 4.38%
+750,000
NUVB icon
7
Nuvation Bio
NUVB
$1.91B
$3.58M 4.17%
+400,000
BBIO icon
8
BridgeBio Pharma
BBIO
$12.8B
$2.75M 3.2%
+36,000
PTCT icon
9
PTC Therapeutics
PTCT
$5.44B
$2.73M 3.18%
+36,000
UTHR icon
10
United Therapeutics
UTHR
$23B
$2.68M 3.12%
+5,500
BCRX icon
11
BioCryst Pharmaceuticals
BCRX
$1.87B
$2.34M 2.72%
+300,000
PCVX icon
12
Vaxcyte
PCVX
$9.05B
$2.31M 2.68%
+50,000
GMAB icon
13
Genmab
GMAB
$18B
$2.16M 2.51%
+70,000
SNDX icon
14
Syndax Pharmaceuticals
SNDX
$1.8B
$2.1M 2.45%
+100,000
VSTM icon
15
Verastem
VSTM
$439M
$2.08M 2.43%
+270,000
TARS icon
16
Tarsus Pharmaceuticals
TARS
$3.08B
$1.97M 2.29%
+24,000
APOG icon
17
Apogee Enterprises
APOG
$858M
$1.89M 2.2%
+25,000
ZNTL icon
18
Zentalis Pharmaceuticals
ZNTL
$160M
$1.78M 2.07%
+1,320,000
INSM icon
19
Insmed
INSM
$31.7B
$1.74M 2.03%
+10,000
SLN
20
Silence Therapeutics
SLN
$253M
$1.46M 1.7%
+240,000
EWTX icon
21
Edgewise Therapeutics
EWTX
$3.19B
$1.44M 1.68%
+58,000
BEAM icon
22
Beam Therapeutics
BEAM
$3B
$1.39M 1.61%
+50,000
ORIC icon
23
Oric Pharmaceuticals
ORIC
$1.31B
$1.31M 1.52%
+160,000
APLS icon
24
Apellis Pharmaceuticals
APLS
$2.71B
$1.26M 1.46%
+50,000
DNLI icon
25
Denali Therapeutics
DNLI
$3.48B
$1.16M 1.35%
+70,000